Director, Gross-to-Net Accounting

Industry: Biopharma | Public Company

Modernized legacy systems. Improved pricing accuracy. Promoted within a year.

A publicly traded pharmaceutical company needed a Director of GTN Accounting to modernize legacy systems and improve pricing accuracy across the U.S. market. After multiple failed searches, they turned to us. We identified a candidate with relevant experience from a mid-cap pharma competitor who also brought strong SOX compliance capabilities. The role was filled in 45 days, and the hire was promoted to Executive Director within a year.

"What impressed me most was their ability to speak the language of our internal finance team and quickly bring us candidates who weren’t just qualified but also aligned with our culture."
– VP, Corporate Finance

G2 Results:

Filled in 45 days

3 finalists

Internal promotion in 12 months